What is the Market's View on G1 Therapeutics Inc (GTHX) Stock's Price and Volume Trends Thursday?

Overall market sentiment has been high on G1 Therapeutics Inc (GTHX) stock lately. GTHX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

G1 Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on GTHX!

See Full GTHX Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With GTHX Stock Today?

G1 Therapeutics Inc (GTHX) stock is higher by 11.76% while the S&P 500 is lower by -0.24% as of 1:33 PM on Thursday, Nov 30. GTHX is higher by $0.20 from the previous closing price of $1.70 on volume of 985,697 shares. Over the past year the S&P 500 is higher by 14.71% while GTHX is lower by -66.31%. GTHX lost -$1.47 per share in the over the last 12 months. To screen for more stocks like G1 Therapeutics Inc click here.

More About G1 Therapeutics Inc

G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer, such as cell lung cancer and breast cancer, and designs them to combine - and enhance - the anti-tumor activity of current therapies. Click Here to get the full Stock Report for G1 Therapeutics Inc stock.